Both in Pharmaceuticals
Curanex Pharmaceuticals vs GT Biopharma
Over the past year CURX returned −51.7% and GTBP returned −68.7%; their daily moves had a correlation of 0.02.
CURX −51.7% GTBP −68.7%Growth of $1, one year, split-adjusted
| Metric | CURX | GTBP |
|---|---|---|
| Price | $5.80 | $4.84 |
| Market cap | $9.1M | $8.7M |
| Today | −6.30% | −8.16% |
| 1 month | +16.2% | −24.0% |
| 6 months | −17.7% | −51.9% |
| Year to date | −12.3% | −75.3% |
| 1 year | — | −68.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $2.9M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 905.2% | 958.4% |
| Short % of float | 0.1% | 24.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).